Filter
492
Filtered Results: 492
Text search:
genotypic
testing
Featured
Recommendations
63
New Publications
141
Language
Document type
No document type
292
Guidelines
89
Studies & Reports
61
Manuals
25
Strategic & Response Plan
14
Fact sheets
6
Brochures
2
Training Material
1
Situation Updates
1
Infographics
1
Countries / Regions
India
22
Western and Central Europe
19
Eastern Europe
11
Africa
10
South Africa
10
Rwanda
9
Nigeria
9
Latin America and the Carribbean
9
Ethiopia
9
Nepal
7
Global
7
Russia
7
Namibia
6
Zambia
6
Kenya
5
Malawi
5
Philippines
5
Mozambique
5
Sierra Leone
4
Peru
4
Zimbabwe
4
Asia
4
Germany
4
South–East Asia Region
4
Bangladesh
4
Myanmar / Burma
4
Ukraine
3
Cameroon
3
Cambodia
3
Tanzania
3
Indonesia
3
North Macedonia
2
Colombia
2
Lesotho
2
Ghana
2
Estonia
2
USA
2
Venezuela
2
Congo, Democratic Republic of
2
Western Pacific Region
2
Argentina
2
Uganda
2
Brazil
2
Georgia
2
Botswana
2
Liberia
2
Timor Leste/ East Timor
1
Thailand
1
Benin
1
Togo
1
Chile
1
Iran
1
Albania
1
Senegal
1
Jordan
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Portugal
1
Bolivia
1
Central African Republic
1
Mali
1
Angola
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
144
Clinical Guidelines
92
Public Health
23
Pharmacy & Technologies
19
Key Resources
9
Women & Child Health
5
Capacity Building
3
Toolboxes
TB
111
HIV
71
AMR
27
NTDs
25
COVID-19
17
Pharmacy
15
Rapid Response
14
Refugee
14
Mental Health
10
Planetary Health
6
Zika
6
Ebola & Marburg
5
NCDs
5
Polio
5
Caregiver
3
Natural Hazards
2
Cholera
2
Conflict
2
Specific Hazards
1
Disability
1
Malaria
1
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
Unofficial Translation
Approved by the Federal Government on October 20, 2016
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
Technical Brief
Damon Barrett, Gonçalo Figueiredo Augusto, Martiani Oktavia, Jeanette Olsson, Mira Schneiders and Kate Welch provided background papers and literature reviews which informed this technical series.
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes
